ArticleTheranostics2019
CapG promotes resistance to paclitaxel in breast cancer through transactivation of PIK3R1/P50.
Yayun Chi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
43 papers cite it
this papercites it
ArticleTheranostics2019
Yayun Chi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.